The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
about
Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin systemThe role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)Angiotensin signalling in pulmonary fibrosisEmerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part II: Neurohormonal Signaling Contributes to the Pulmonary Vascular and Right Ventricular Pathophenotype of Pulmonary Arterial HypertensionDirect isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differencesAngiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathwayOral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension.Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNAACE2 improves right ventricular function in a pressure overload model.Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.Angiotensin-converting enzyme 2 decreases formation and severity of angiotensin II-induced abdominal aortic aneurysmsRenin and cardiovascular disease: Worn-out path, or new direction.The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.New perspectives for the treatment of pulmonary hypertensionAngiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-κB pathwaysChronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.Chronic ANG II infusion induces sex-specific increases in renal T cells in Sprague-Dawley ratsSelective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammationThe genetics of pulmonary arterial hypertension in the post-BMPR2 era.Inhibition of extracellular signal-regulated kinases ameliorates hypertension-induced renal vascular remodeling in rat modelsACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease TherapyBeneficial effects of long-term administration of an oral formulation of Angiotensin-(1-7) in infarcted rats.Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertensionAngiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome.Angiotensin converting enzyme 2: a new important player in the regulation of glycemia.Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes.Dose-dependent, therapeutic potential of angiotensin-(1-7) for the treatment of pulmonary arterial hypertensionThe renin-angiotensin system and right ventricular structure and function: The MESA-Right Ventricle Study.RAS-Mediated Adaptive Mechanisms in Cardiovascular Tissues: Confounding Factors of RAS Blockade Therapy and Alternative Approaches.Alternative Roles of STAT3 and MAPK Signaling Pathways in the MMPs Activation and Progression of Lung Injury Induced by Cigarette Smoke Exposure in ACE2 Knockout MiceTherapeutic time window for angiotensin-(1-7) in acute lung injuryACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.Angiotensin-(1-7)/mas inhibits apoptosis in alveolar epithelial cells through upregulation of MAP kinase phosphatase-2.Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1/2 and NF-κB signaling pathwaysPrior hypoxia prevents downregulation of ACE-2 by hyperoxia in fetal human lung fibroblasts.Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7.Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models.Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.
P2860
Q26996208-7C6930D0-050A-437C-919E-54FD4AB95353Q27013946-AAB8714D-2A21-4231-82F9-7FCC11D30525Q27025157-45BA19F2-F649-4564-9BCE-434D0819B100Q28085007-5736CE58-3CF6-4698-ABAC-0E879DEF977AQ28387716-CDDDC7F1-30AD-4135-87F8-EFF7D9F51832Q28565300-B05938E2-B097-4A45-A8F6-2D540867DE45Q30600509-CB2170AA-B104-4954-8E98-E21E2AD205EDQ33652543-8F51D068-ADBD-458E-8B35-2E17A9C6BB11Q33939495-AA037E42-5BE1-48E4-AABA-046C258F3788Q34001678-3BEBEDA3-356B-4A3F-8FBC-CD4CDC3B7F0EQ34606642-EC567F6B-B262-4D4A-B2B0-544BD61132FCQ34801804-C0B79E33-9780-4132-BB1A-7837E165509AQ34811358-6088C9D9-1D43-4A84-A22C-E6773CCA64C9Q34903204-5A84053F-D147-4619-969D-DCCC6CAD36E6Q35040846-17F03898-7947-492E-BF87-3A5BDE1B869AQ35053205-E4726CAC-4B1E-405E-9DB3-63439FA2D0BDQ35274058-452E24D6-66EF-4FC2-B81C-0D2ACE65224BQ35484295-9A43D971-334D-49D2-A4A7-5712A30711BEQ35484382-286F13B1-5623-4516-BA7F-1DB2F94024F8Q35573919-EF3D825D-AEED-4FF8-9476-B4F083F22EADQ35669406-CA1BABC0-FA74-4996-9165-7256C7B284B8Q35760437-AC328CC6-511E-452F-BE16-4977CF93AA1EQ35811007-D2DF62ED-871A-4EF4-B880-EDEA99036547Q35850232-EB512DF8-0EB7-4E9B-9167-D267AE175B5EQ35883490-2F399F89-52D4-442F-8D12-0C25E05F7D63Q36020040-9F4CF8BE-D130-41E8-8118-34E2402AB29AQ36042210-9293E975-C9A4-466B-8BB4-ABDFD9AE269CQ36352087-697D419B-89D0-496C-8D79-7FD910A299EDQ36366106-57F24C52-AF10-4E9B-96E9-7F6ACF1DB307Q36551388-059684F1-9D5A-402A-9A6A-92F445C9FDA9Q36727116-33FAEDB0-10D7-4847-8E39-3BAD92C36A3DQ36830120-6F5DF031-974B-4FAF-BD84-2500EB7EAB23Q36929414-6505D08F-1749-4669-A35F-87D50EBC418DQ36955317-6F431D8B-7A42-4959-841D-3DE0A5B5FB60Q37005635-FD1E9883-CE6B-46DE-905D-9C4F95561C04Q37025968-7D4C3764-A795-4E50-8AE8-EFCA50AEC757Q37054471-E4965F1C-332D-42D2-95F9-DA6D0ED43774Q37070077-BA6F9118-5881-4E39-B84C-AF015B95F8DEQ37127739-C5FA8EC5-C829-4D54-BDA7-703A804D549AQ37147092-F6CD672D-A53E-4928-81AE-66F8E274F0CD
P2860
The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The angiotensin-converting enzyme 2/angiogenesis-
@nl
The angiotensin-converting enz ...... is and pulmonary hypertension.
@ast
The angiotensin-converting enz ...... is and pulmonary hypertension.
@en
type
label
The angiotensin-converting enzyme 2/angiogenesis-
@nl
The angiotensin-converting enz ...... is and pulmonary hypertension.
@ast
The angiotensin-converting enz ...... is and pulmonary hypertension.
@en
prefLabel
The angiotensin-converting enzyme 2/angiogenesis-
@nl
The angiotensin-converting enz ...... is and pulmonary hypertension.
@ast
The angiotensin-converting enz ...... is and pulmonary hypertension.
@en
P2093
P2860
P1476
The angiotensin-converting enz ...... is and pulmonary hypertension.
@en
P2093
Anderson J Ferreira
Autumn Dooies
Carlos Díez-Freire
Changaram S Venugopal
Dorna Pourang
Jawaharlal M Patel
Joo Yun Jun
Joseph Francis
Michael J Katovich
Mohan K Raizada
P2860
P304
P356
10.1164/RCCM.200912-1840OC
P407
P577
2010-06-25T00:00:00Z